481 Results (Page 19 of 20)
UK Markets Research Reports
UK PET Scan Market Analysis
The UK PET Scan Market was valued at $50.4 Mn in 2023 and is predicted to grow at a CAGR of 3.4% from 2023 to 2030, to $63.7 Mn by 2030. The key drivers of the market include the rise in elderly population, increasing prevalence of chronic diseases, and increasing healthcare expenditure. The prominent players of the UK PET Scan Market are Siemens Healthineers, Toshiba, GE Healthcare, Hitachi, Canon Medical Systems, among others.
UK Genomic Diagnostics Market Analysis
UK Genomic Diagnostics Market was valued at $848.90 Mn in 2023 and is predicted to grow at a CAGR of 14.5% from 2023 to 2030, to $2,190.26 Mn by 2030. The key drivers of this industry include rising disease incidence, increased government support, and growing public awareness. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
UK Mouth Ulcer Therapeutics Market Analysis
The UK Mouth Ulcer Therapeutics Market was valued at $39.5 Mn in 2023 and is projected to grow at a CAGR of 1.9% from 2023 to 2023, to $45.1 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Bayer, MSD, Bristol-Myers Squibb Company, Colgate-Palmolive Company, GlaxoSmithKline PLC, Pfizer, Dr Reddy, Cipla, Pulse Pharmaceuticals among others.
UK Bio-implant Market Analysis
The UK Bio-implant Market was valued at $1690 Mn in 2023 and is predicted to grow at a CAGR of 3.9% from 2023 to 2030, to $2209 Mn by 2030. The UK Bio-implant Market is growing due to Patient Preference for Minimally Invasive Procedures, Rising Chronic Diseases, and Government Initiatives and Funding. The market is primarily dominated by players such as Smith & Nephew, Zimmer Biomet, Stryker Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, Medtronic plc, Boston Scientific Corporation, and Johnson & Johnson Services.
UK Compression Therapy Market Analysis
UK Compression Therapy Market was valued at $99 Mn in 2022 and is estimated to reach $131 Mn in 2030, exhibiting a CAGR of 3.6% during the forecast period. The rising prevalence of venous conditions like leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots is a significant driver for the growth of the compression therapy market. Key players in this industry encompass entities such as Sigvaris, Medi, Juzo, Jobst, Bauerfeind, LymphoCare, Activa Healthcare, Amoena, Ofa Bamberg, and Variteks.
UK CT Scan Market Analysis
UK CT Scan Market was valued at $119.86 Mn in 2023 and is predicted to grow at a CAGR of 5.87% from 2023 to 2030, to $178.68 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, technological advancements in CT scanners, and the growing geriatric population. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
UK Lipid Disorder Therapeutics Market Analysis
The UK Lipid Disorder Therapeutics Market was valued at $16.2 Mn in 2023 and is predicted to grow at a CAGR of 12.83% from 2023 to 2030, to $37.8 Mn by 2030. UK Lipid Disorder Therapeutics Market is growing due to the Increasing Prevalence of Cardiovascular Diseases, Government & NHS Support, Technological Advancements, and Personalized Medicine. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
UK Mental Health Apps Market Analysis
The UK Mental Health Apps Market was valued at $161.2 Mn in 2023 and is predicted to grow at a CAGR of 13.2% from 2023 to 2030, to $383.96 Mn by 2030. The key drivers of this industry include reduced stigma, increasing smartphone penetration, and advancement in technology. The industry is primarily dominated by players such as Headspace, Calm, Happify, and Unmind among others.
UK Cough Hypersensitivity Syndrome Therapeutics Market Analysis
The UK Cough Hypersensitivity Syndrome Therapeutics Market was valued at $211 Mn in 2022 and is predicted to grow at a CAGR of 3.9% from 2023 to 2030, to $286 Mn by 2030. The key drivers of this industry include the rising prevalence of Cough Hypersensitivity Syndrome, the evolving treatment landscape, and supportive regulatory policies. The industry is primarily dominated by players such as Johnson & Johnson, GSK, Merck, Novartis, AstraZeneca, and Pfizer among others.
UK Herbal Supplements Market Report
The UK Herbal Supplements Market was valued at $136.76 Mn in 2023 and is predicted to grow at a CAGR of 4.2% from 2023 to 2030, to $182.40 Mn by 2030. The key drivers of this industry include rising consumer preference, increased supplement consumption, and the prevalence of a sedentary lifestyle. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife, NOW Foods, Botanic Supplements, and Dabur among others.
UK Actinic Keratosis Therapeutic Market Analysis
The UK Actinic Keratosis Therapeutic Market is predicted to develop at a CAGR of 2.9%, increasing from $177 Mn in the year 2022 to $222 Mn by the year 2030. The UK Actinic Keratosis Therapeutic Market is expected to grow at a faster rate during the forecast period, owing to a large patient population, increased awareness about the prevention and treatment of Actinic Keratosis, and advancements in medical technology leading to the development of innovative and minimally invasive procedures. Some domestic firms, such as GlaxoSmithKline and Scancell, as well as international Sun Pharmaceuticals, Biofrontera, Nestle, Bausch Health, etc are key competitors in the industry
UK Constipation Therapeutics Market Analysis
UK Constipation Therapeutics Market was valued at $473 Mn in 2022 and is estimated to reach $673 Mn in 2030, exhibiting a CAGR of 4.5% during the forecast period. The constipation therapeutics market is experiencing growth driven by the rising prevalence of constipation worldwide, attributed to factors like aging, sedentary lifestyles, and unhealthy dietary habits, with the expanding elderly population, more prone to chronic conditions, further contributing to this market expansion. Notable participants in this industry include AbbVie, Almirall, Boehringer Ingelheim, Ferring Pharmaceuticals, Johnson & Johnson, Norgine Pharmaceuticals, Pfizer, Recordati, Sanofi, and Takeda Pharmaceuticals.
UK Brugada Syndrome Market Analysis
The UK Brugada Syndrome Market was valued at $31.2 Mn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $46.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increasing awareness and diagnosis, and advancements in genetic testing. The prominent players of the UK Brugada Syndrome Market are AstraZeneca, Hikma, GlaxoSmithKline, Accord, Siemens Healthineers, Abbott, and Thermo Fisher Scientific, among others.
UK Clinical Nutrition for Chronic Kidney Diseases Market Analysis
UK Clinical Nutrition for Chronic Kidney Diseases Market was valued at $40.80 Mn in 2023 and is predicted to grow at a CAGR of 4.03% from 2023 to 2030, to $53.80 Mn by 2030. The key drivers of this industry include the rising prevalence of CKD, technological advancements, and the growing geriatric population. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
UK Dental Endodontics Market Analysis
UK Dental Endodontics Market was valued at $45.50 Mn in 2023 and is predicted to grow at a CAGR of 2.3% from 2023 to 2030, to $53.40 Mn by 2030. The key drivers of this industry include rising demand for tooth preservation, an aging population, technological advancements, and increased awareness. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
UK Blood Disorder Therapeutics Market
UK Blood Disorder Therapeutics Market valued at $348 Mn in 2022, projected to reach $535 Mn by 2030 with a 5.5% CAGR. Increased disease incidence brought on by changes in demographics and lifestyle, government support for healthcare accessibility, and the significant role patient advocacy groups play in spreading awareness and developing cutting-edge therapies are the main drivers of this industry. The UK Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Sanofi, Novo Nordisk, CSL Ltd, Bayer, Celgene, Global Blood Therapeutics, Novartis, Emmaus Life Sciences, Bluebird Bio, etc, among various others.
UK Breast Pump Market Report
The UK Breast Pump Market was valued at $76.4 Mn in 2023 and is predicted to grow at a CAGR of 6.6% from 2023 to 2030, to $119.6 Mn by 2030. The key drivers of the market include the rising female workforce, enhanced features, and consumer awareness. The prominent players in the UK Breast Pump Market are Elvie, Ardo, Tommee Tippee, Koninklijke Philips, Canpol Babies, and Chicco, among others.
UK Cancer Induced Bone Diseases Therapeutics Market
UK Cancer Induced Bone Disease Therapeutics Market valued at $34 Mn in 2022, projected to reach $46 Mn by 2030 with a 3.8% CAGR. The key drivers of this industry include the rising incidence of cancers, a favorable regulatory environment, and technological advancements. The industry is primarily dominated by players such as Advaxis, Takeda, Gradalis, Johnson & Johnson, Hikma, Cellectar, and Amgen among others.
UK Digital Biomarkers Market Analysis
UK Digital Biomarkers Market was valued at $75.40 Mn in 2023 and is predicted to grow at a CAGR of 20.3% from 2023 to 2030, to $274.94 Mn by 2030. The key drivers of this industry include the high prevalence of chronic diseases, focus on preventative healthcare, government initiatives, and growing interest in personalized medicine. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
UK Cardiac Resynchronization Therapy Market
UK Cardiac Resynchronization Therapy Market valued at $125 Mn in 2022, projected to reach $158 Mn by 2030 with a 3% CAGR. The worldwide increase in heart failure instances, propelled by aging demographics and cardiovascular diseases linked to lifestyle, stands as a pivotal factor fuelling the growth of the Cardiac Resynchronization Therapy (CRT) market. Presently, key players in this market encompass Abbott, Boston Scientific, Biotronik, Medtronic, St. Jude Medical, Sorin Group, LivaNova, MicroPort Aps, Osypka Med and Terumo Corporation.
UK Congestive Heart Failure Therapeutics Market Analysis
The UK Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $268 Mn in 2022 to $361 Mn by 2030, with a CAGR of 3.8% during the forecast period of 2022-2030. The key drivers include the escalating prevalence of risk factors, continuous innovations in CHF therapies, and an increased government healthcare expenditure, fostering improved access, all collectively propelling market growth. The UK Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including AstraZeneca, Novartis, Boehringer Ingelheim, Amgen, Bristol-Myers Squibb, Johnson and Johnson, Eli Lilly, Hikma Pharmaceuticals, Wockhardt, Medivet Pharmaceuticals, etc., among various others.
UK Exosome Research Market Analysis
The UK Exosome Research Market was valued at $4.4 Mn in 2023 and is projected to grow at a CAGR of 14% from 2023 to 2023, to $11 Mn by 2030. The key drivers of this industry are increasing prevalence and incidences of cancer and various auto-immune diseases, rising healthcare expenditure for better health services, growing R&D activities associated with exosome research, technological advancements in exosome isolation and analytical procedures, increasing advanced applications of exosomes. The industry is primarily dominated by players such as AMS Biotechnology, Evox Therapeutics, Thermo Fisher Scientific among others.
UK Physiotherapy Equipment Market Analysis
The UK Physiotherapy Equipment Market was valued at $543.40 Mn in 2023 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $774.87 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are Invacare, Dynatronics, Enraf-Nonius BV, and Wessex Lift Co Ltd among others.
UK Patient Adherence Programs Market Analysis
The UK Patient Adherence Programs Market was valued at $336.9 Mn in 2023 and is predicted to grow at a CAGR of 16% from 2023 to 2030, to $952 Mn by 2030. The key drivers of the market include increasing non-adherence, rising awareness, and technological innovations. The prominent players of the UK Patient Adherence Programs Market are AstraZeneca, Johnson & Johnson, Bayer, GSK, Merck, and Novartis, among others.
UK Dental Consumables Market Analysis
The UK Dental Consumables Market was valued at $878.8 Mn in 2023 and is projected to grow at a CAGR of 6.0% from 2023 to 2023, to $1321.4 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as Ultradent Products, Henry Schein, Dentsply Sirona, 3M Oral Care, Carestream Dental among others.